Newstral
Article
Iinvezz.com on 2022-04-12 14:38
Bicycle Therapeutics reports promising BT8009 study results, shares tank 30%
Related news
- MUPDATE: Cara Therapeutics shares surge 13.7% premarket on positive trial resultsmarketwatch.com
- Bicycle Therapeutics deal for haemophilia and sickle cell disease therapies could be worth $410millioncambridgeindependent.co.uk
- Steven Cohen Shifts Into A Higher Gear With Bicycle TherapeuticsForbes
- Bicycle Therapeutics scores $555M investment for disease preventiontech.eu
- MBicycle Therapeutics shares slide 10.7% in trading debutmarketwatch.com
- IStructure Therapeutics reports promising results for weight-loss pillinvezz.com
- Coronavirus vaccine trial shows promising early resultsStar Tribune
- BChinese coronavirus vaccine trials show promising resultsbgr.com
- Canadian Ebola Vaccine Trial Reveals Promising Resultshuffingtonpost.ca
- Bind Therapeutics shares soar as firm expands lung cancer trialsbizjournals.com
- Coronavirus | Covaxin phase-1 trial results show promising resultsThe Hindu
- Cancer Research UK to fund clinical trial of Bicycle Therapeutics immuno-oncology candidatecambridgeindependent.co.uk
- Cesca Therapeutics shares jump on positive results from clinical studybizjournals.com
- MRegulus Therapeutics stock surges after 'promising' Hep C drug trial resultsmarketwatch.com
- University of Oxford vaccine trial shows promising early resultsCNN
- ECOVID-19 Vaccine Tests at Emory Yield Promising Resultsemorywheel.com
- Personalized therapy for aggressive brain cancer shows promising resultsnewatlas.com
- First COVID-19 vaccine tested in U.S. shows promising resultsThe Hindu
- Ebola vaccine trials yield promising results two years after startnation.co.ke
- Early trials for coronavirus vaccine show 'promising' resultsCNN